Enliven 制药 ELVN
$49.43 +$4.64 (+10.36%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $49.75 +0.65%
开盘$46.19
昨收$44.79
当日区间$44.55 – $49.66
成交量969.8K
市值$3.64B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例115.9%+3.31 个百分点，较上季度
持仓机构数260+9 ，较上季度
内部人近期交易15次买入 / 35次卖出净卖出
空头持仓比例12.74% 占流通股回补天数 7.5 · 截至 15 Oct 2026
卖空成交量占比14.5%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$8.25M（10个净流入日，10个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有44.3%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从11.41%升至12.74%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +847,399 | 1.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +846,877 | 7.1% |
| Westfield Capital Management Company, L.P. | Mutual Fund | 2026/Q3 | +341,586 | 0.5% |
| FMR | Mutual Fund | 2026/Q3 | +3,195,768 | 13.7% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +3,107,051 | 4.4% |
| Norges Bank Investment Management | Sovereign Wealth Fund | 2026/Q3 | +1,382,333 | 1.9% |
| Polar Capital Holdings Plc | Mutual Fund | 2026/Q3 | +1,364,703 | 8.8% |
| First Light Asset Management, LLC | Mutual Fund | 2026/Q3 | +1,158,883 | 1.9% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,083,313 | 1.5% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +1,028,185 | 2.4% |
| Samlyn Capital, LLC | Hedge Fund | 2026/Q3 | +912,637 | 1.2% |
| Tri Locum Partners LP | Hedge Fund | 2026/Q3 | +866,716 | 1.2% |
| Vestal Point Capital, LP | Hedge Fund | 2026/Q3 | +750,000 | 5.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +674,997 | 6.0% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +593,122 | 0.8% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 18 Oct 2026 | Helen Collins | Chief Medical Officer | Derivative Exercise and Sale | -5,000 | $38.47 | 25,000 |
| 18 Oct 2026 | Benjamin Hohl | CFO & Head of Corporate Development | Derivative Exercise and Sale | -6,018 | $38.48 | 13,000 |
| 13 Oct 2026 | Kristine Ball | Director | Other Derivative Acquisition | +23,394 | $39.28 | 23,394 |
| 30 Sep 2026 | Scott Garland | Director | Derivative Exercise and Sale | -13,000 | $46.67 | – |
| 16 Sep 2026 | Helen Collins | Chief Medical Officer | Derivative Exercise and Sale | -5,000 | $51.48 | 25,000 |
| 16 Sep 2026 | Benjamin Hohl | CFO & Head of Corporate Development | Open Market Disposition | -2,036 | $51.49 | 13,000 |
| 16 Sep 2026 | Benjamin Hohl | CFO & Head of Corporate Development | Derivative Exercise and Sale | -3,982 | $50.72 | 13,000 |
| 3 Sep 2026 | Richard Heyman | Former Independent Chairperson | Intent to Sell (Form 144) | -38,000 | $59.29 | – |
| 16 Aug 2026 | Helen Collins | Chief Medical Officer | Derivative Exercise and Sale | -5,000 | $59.35 | 25,000 |
| 16 Aug 2026 | Benjamin Hohl | CFO & Head of Corporate Development | Automatic Disposition | -6,018 | $59.35 | 15,036 |
| 3 Aug 2026 | Mika Derynck | Independent Director | Derivative Exercise and Sale | -158,795 | $60.21 | – |
| 16 Jul 2026 | Helen Collins | Chief Medical Officer | Derivative Exercise and Sale | -5,000 | $53.92 | 25,000 |
| 16 Jul 2026 | Benjamin Hohl | CFO & Head of Corporate Development | Automatic Disposition | -4,946 | $53.87 | 21,054 |
| 16 Jul 2026 | Benjamin Hohl | CFO & Head of Corporate Development | Derivative Exercise and Sale | -1,072 | $52.32 | 21,054 |
| 5 Jul 2026 | Lori Kunkel | Independent Director | Automatic Disposition | -10,000 | $50.84 | 41,884 |
| 21 Jun 2026 | OrbiMed Advisors LLC | Private Disposition | -48,253 | $45.00 | 6,774,507 | |
| 21 Jun 2026 | OrbiMed Advisors LLC | Open Market Disposition | -811,870 | $45.38 | 6,774,507 | |
| 16 Jun 2026 | Helen Collins | Chief Medical Officer | Derivative Exercise and Sale | -5,000 | $44.74 | 25,000 |
| 16 Jun 2026 | Benjamin Hohl | CFO & Head of Corporate Development | Derivative Exercise and Sale | -6,018 | $44.75 | 26,000 |
| 14 Jun 2026 | OrbiMed Advisors LLC | Open Market Disposition | -281,408 | $45.02 | 7,634,630 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 9,331,398 | 12.7% | 7.5 |
| 30 Sep 2026 | 10,356,282 | 14.1% | 5.5 |
| 15 Sep 2026 | 8,620,503 | 11.8% | 9.0 |
| 31 Aug 2026 | 8,600,289 | 11.7% | 11.1 |
| 14 Aug 2026 | 8,258,991 | 11.3% | 6.3 |
| 31 Jul 2026 | 8,151,554 | 11.4% | 11.4 |
暂无评论——快来第一个聊聊 ELVN。
登录后参与讨论。